The promise of cancer immunotherapy: from research and industry to the clinic

The treatment of cancer has long rested on three pillars: chemotherapy, surgery, and radiation. But in recent years, a fourth pillar has emerged: immunotherapy. The idea of harnessing the immune system to fight cancer has already moved from the lab to the clinic, thanks to technologies such as checkpoint inhibitors and genetically engineered immune cells. Ton Schumacher and Hans van Eenennaam will discuss how immunotherapy is starting to revolutionize the treatment of cancer.

Continue reading